Sun Pharma gains after bulk deal

Sun Pharmaceutical Industries rose 1.15% to Rs 860.50 at 10:31 IST on BSE after 0.07% equity changed hands in a bulk deal on BSE today, 19 January 2015.

A bulk deal of 15.59 lakh shares was executed on the Sun Pharmaceutical Industries counter at Rs 859.70 per share at 09:34 IST on BSE today, 19 January 2015.

Meanwhile, the BSE Sensex was up 180.88 points, or 0.64%, to 28,302.77

Bulk deal boosted volume on the scrip. On BSE, so far 16.20 lakh shares were traded in the counter, compared with an average volume of 1.71 lakh shares in the past one quarter.

The stock hit a high of Rs 865 and a low of Rs 853.55 so far during the day. The stock hit a record high of Rs 932 on 10 November 2014. The stock hit a 52-week low of Rs 552.50 on 14 March 2014.

The stock had underperformed the market over the past one month till 16 January 2015, rising 2.51% compared with Sensex's 5.01% rise. The scrip had also underperformed the market in past one quarter, rising 6.76% as against Sensex's 8.16% rise.

The large-cap pharma firm has an equity capital of Rs 207.12 crore. Face value per share is Re 1.

The Competition Commission of India in its meeting held on 5 December 2014 had approved the proposed merger between Sun Pharmaceutical Industries and Ranbaxy Laboratories. In April 2014, Sun Pharmaceutical Industries had acquired Ranbaxy Laboratories in $4 billion landmark transaction.

Sun Pharma's consolidated net profit rose 15.4% to Rs 1572.46 crore 11.8% rise in total income to Rs 4822.15 crore in Q2 September 2014 over Q2 September 2013.

Sun Pharmaceutical Industries is an international specialty pharmaceutical company.

Powered by Capital Market - Live News